Three Months Ended

Twelve Months Ended

(In Millions, Except Per Share Amounts)

Dec 30,
2017

Dec 31,
2016

Dec 30,
2017

Dec 31,
2016

NET REVENUE

$

17,053

$

16,374

$

62,761

$

59,387

Cost of sales

6,286

6,269

23,692

23,196

GROSS MARGIN

10,767

10,105

39,069

36,191

Research and development

3,274

3,280

13,098

12,740

Marketing, general and administrative

1,850

2,158

7,474

8,397

R&D AND MG&A

5,124

5,438

20,572

21,137

Restructuring and other charges

195

100

384

1,886

Amortization of acquisition-related intangibles

53

41

177

294

OPERATING EXPENSES

5,372

5,579

21,133

23,317

OPERATING INCOME

5,395

4,526

17,936

12,874

Gains (losses) on equity investments, net

1,211

18

2,651

506

Interest and other, net

(571)

(104)

(235)

(444)

INCOME BEFORE TAXES

6,035

4,440

20,352

12,936

Provision for taxes

6,722

878

10,751

2,620

NET INCOME (LOSS)

$

(687)

$

3,562

$

9,601

$

10,316

BASIC EARNINGS PER SHARE OF COMMON STOCK

$

(0.15)

$

0.75

$

2.04

$

2.18

DILUTED EARNINGS PER SHARE OF COMMON STOCK

$

(0.15)

$

0.73

$

1.99

$

2.12

WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING:

BASIC

4,683

4,735

4,701

4,730

DILUTED

4,683

4,881

4,835

4,875